OpioidRedoxStudyII
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorEPC Education s.r.o.
About this trial
This observational study aims to examine the relationship between opioid use and redox balance in adults. Redox balance reflects the level of oxidative stress in the body, which is known to play an important role in many biological processes and diseases.
Participants who use opioids will be included in the study. No experimental treatment or changes to current medical care will be provided as part of this study. Biological samples may be collected to assess redox-related biomarkers, and relevant clinical and demographic information will be recorded.
The results of this study are expected to improve understanding of how opioid exposure is associated with redox balance in adults. This information may help inform future research on the biological effects of opioids and potential strategies to reduce harm associated with long-term opioid use.
Eligibility criteria
Qualifiers
Adults aged 18 years or older
Receiving opioid therapy (tramadol, tapentadol, morphine, fentanyl, or buprenorphine) as part of routine clinical care
Stable opioid treatment for at least a predefined minimum period prior to enrollment (according to the study protocol)
Ability to provide written informed consent
Disqualifiers
Acute opioid intoxication or withdrawal at the time of enrollment
Use of investigational drugs or participation in another interventional clinical trial that could interfere with study outcomes
Severe acute illness or unstable medical condition that, in the investigator's judgment, would interfere with study participation
Known pregnancy or breastfeeding
Trial design
Treatments tested in this trial
- Not listed
Trial groups
120 Participants
are grouped into 4 trial groupsSponsors and collaborators
EPC Education s.r.o.
Lead sponsor
Pavol Jozef Safarik University
Collaborator
F.D.Roosevelt Banska Bystrica Slovak Republic
Collaborator
Source ClinicalTrials.gov